Gadolinium-Based Contrast Agents

Gadolinium-based contrast agents (GBCAs), also known as MRI contrast dyes, contain toxic metals that can be retained in the body. Patients who had MRI dye administered intravenously may develop serious, long-lasting issues.

Read more about Gadolinium-Based Contrast Agents

Woman going into an MRI machine representing the GBCA chemical toxicity suit.

GBCA Chemical Toxicity Suit Weathers Dismissal Claims

James Parker · July 2, 2020

The plaintiff claims that the GBCAs used in her MRIs in 2015 caused a condition known as gadolinium deposition disease (GDD) and a host of debilitating side effects.

Legal Developments
An elderly man clutching his chest, representing a new test to detect coronary artery disease without GBCAs.

New Screening for Coronary Artery Disease Developed, Without Contrast Agents

Carah Wertheimer · August 12, 2019

A new test to detect coronary artery disease in just 15 minutes with a basic MRI is currently being developed by Boston researchers. It wouldn't require the use of controversial, potentially toxic gadolinium-based contrast agents (GBCAs).

MedTech
Photo of Gena and Chuck Norris at rally for gadolinium toxicity poisoning.

Gena and Chuck Norris Raise Awareness About Dangers of MRI Dye

S. Nicole Lane · September 11, 2018

Actor Chuck Norris and his wife Gena are speaking out about the effects of gadolinium toxicity poisoning, which may be caused by contrast agents used during MRIs.

News